Aqua Bio Technology ASA

OB:ABTEC Stock Report

Market Cap: NOK 228.6m

Aqua Bio Technology Balance Sheet Health

Financial Health criteria checks 0/6

Insufficient data to determine the health of Aqua Bio Technology

Key information

n/a

Debt to equity ratio

n/a

Debt

Interest coverage ration/a
Cashn/a
Equityn/a
Total liabilitiesn/a
Total assetsn/a

Recent financial health updates

No updates

Recent updates

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Jan 20
The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Dec 30
Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if ABTEC's short term assets cover its short term liabilities.

Long Term Liabilities: Insufficient data to determine if ABTEC's short term assets cover its long term liabilities.

Debt to Equity History and Analysis

Debt Level: Insufficient data to calculate ABTEC's net debt to equity ratio to determine if it is satisfactory.

Reducing Debt: Insufficient data to determine if ABTEC's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: Insufficient data to determine if ABTEC's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if ABTEC's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 05:11
End of Day Share Price 2024/12/30 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aqua Bio Technology ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tomas SkeivysNorne Securities AS